Search Results

You searched for : dolutegravir  

ViiV Healthcare and Medicines Patent Pool extends voluntary licensing agreement to enable access to long-acting injectable HIV treatment

It builds on the voluntary license for CAB LA for HIV pre-exposure prophylaxis (PrEP), enabling increased access to innovative long-acting injectables for HIV ...
Jul 15

We can do better so that all people with HIV live healthy normal lifespans

People living with HIV must take care of one’s mental health and wellbeing....
Jun 11

Are we on track to end AIDS, end viral hepatitis and end STIs by 2030?

My message is to connect, reconnect, and recommit to ending AIDS by 2030 - and - do it by bringing along other disease areas as well...
Jun 14

ViiV Healthcare receives EU Marketing Authorisation for Tivicay, a treatment for children living with HIV in Europe

Tivicay contains dolutegravir, an integrase strand transfer inhibitor for use in combination with other antiretroviral agents for the treatment of HIV...
Jan 15

ViiV Healthcare receives EU Marketing Authorisation for the first-ever dispersible-tablet formulation of dolutegravir, Tivicay

...
Jan 13

Top Indian Pharma stocks for short term gain : January 2021

Aarti Drugs, Laurus Labs, Granules India, Abbot India, Divis Lab and JB Chem - Medicircle top picks for short term gain...
Jan 13

Top Ten Mid Cap Indian Pharma Stocks ; January 2021

Top ten mid cap Indian pharma stocks , January 2021...
Jan 07

ViiV Healthcare announces CHMP positive opinion for the first-ever dispersible-tablet formulation of dolutegravir, Tivicay, a treatment for children living with HIV in Europe

Dolutegravir is the first integrase inhibitor available as a dispersible tablet for children...
Nov 13

Trial results reveal that long-acting injectable cabotegravir as PrEP is highly effective in preventing HIV acquisition in women

The HIV Prevention Trials Network study (HPTN 084) on the safety and efficacy of the long-acting injectable antiretroviral drug cabotegravir (CAB LA), ...
Nov 10

GSK's Dovato holds against Tenofavir Alafenamide Fumarate for HIV1 patients

GSK two drug combination is as good as 3 drug regimen which is presently continued for HIV 1 patients...
Oct 09

ViiV Healthcare announces dolutegravir plus lamivudine for treatment-naïve adults with HIV-1

Findings showed that the 2-drug regimen (2DR) of dolutegravir plus lamivudine continued to offer non-inferior efficacy...
Oct 05

ViiV Healthcare to present long-term safety and efficacy data for 2-drug regimen

Data presented may shift the treatment paradigm to 2-drug regimens (2DRs) for people living with HIV ...
Oct 01

GSK delivers Q2 sales of £7.6 billion

GSK reports their firs quarter 2020 results...
Jul 30

WHO: access to HIV medicines severely impacted by COVID-19

Countries seek innovative ways to mitigate the impact of disruptions and keep HIV medicine services going ...
Jul 13

14 Matching result(s) found!

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026